Adelaide Research & Scholarship
Browsing "Pharmacology" by Author Ng, H.H.
Showing results 1 to 7 of 7
Preview | Issue Date | Title | Author(s) |
| 2019 | Recent developments in relaxin mimetics as therapeutics for cardiovascular diseases | Leo, C.H.; Jelinic, M.; Ng, H.H.; Parry, L.J.; Tare, M. |
| 2018 | Relaxin as a therapeutic target for the cardiovascular complications of diabetes | Ng, H.H.; Leo, C.H.; Parry, L.J.; Ritchie, R.H. |
| 2019 | Relaxin reduces endothelium-derived vasoconstriction in hypertension: revealing new therapeutic insights | Leo, C.H.; Ng, H.H.; Marshall, S.A.; Jelinic, M.; Rupasinghe, T.; Qin, C.; Roessner, U.; Ritchie, R.H.; Tare, M.; Parry, L.J. |
| 2016 | Serelaxin (recombinant human relaxin-2) prevents high glucose-induced endothelial dysfunction by ameliorating prostacyclin production in the mouse aorta | Ng, H.H.; Leo, C.H.; Parry, L.J. |
| 2016 | Serelaxin: a novel therapeutic for vascular diseases | Leo, C.H.; Jelinic, M.; Ng, H.H.; Tare, M.; Parry, L.J. |
| 2016 | Time-dependent activation of prostacyclin and nitric oxide pathways during continuous i.v. infusion of serelaxin (recombinant human H2 relaxin) | Leo, C.H.; Jelinic, M.; Ng, H.H.; Tare, M.; Parry, L.J. |
| 2017 | Vascular actions of relaxin: nitric oxide and beyond | Leo, C.H.; Jelinic, M.; Ng, H.H.; Marshall, S.A.; Novak, J.; Tare, M.; Conrad, K.P.; Parry, L.J. |